Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model

BACKGROUND: A promising cancer vaccine involves the fusion of tumor cells with dendritic cells (DCs). As such, a broad spectrum of both known and unidentified tumor antigens is presented to the immune system in the context of the potent immunostimulatory capacity of DCs. Murine studies have demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Chunrui, Reddy, Varun, Dannull, Jens, Ding, Enyu, Nair, Smita K, Tyler, Douglas S, Pruitt, Scott K, Lee, Walter T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691646/
https://www.ncbi.nlm.nih.gov/pubmed/23768240
http://dx.doi.org/10.1186/1479-5876-11-148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691646/
https://www.ncbi.nlm.nih.gov/pubmed/23768240
http://dx.doi.org/10.1186/1479-5876-11-148

Ejemplares similares